GlassScriptPhysician profile
Philip Kwok
NPI 1699785006
$3,562.41
in general payments reported to CMS, 2019-2025
16 companies · $990 in 2025
The $990 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $34.48 · 2021: $99.00 · 2022: $236 · 2023: $1,810 · 2024: $71.34 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,640 · Travel and Lodging: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.15 |
| Travel and Lodging | $1,231.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,627.89 | 2023 | Visumax |
| Bausch & Lomb Americas INC. | $467.14 | 2023-2025 | Miebo, Xiidra |
| Glaukos Corporation | $273.77 | 2021-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Tarsus Pharmaceuticals, INC. | $194.97 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $186.10 | 2019 | |
| Abbvie INC. | $125.00 | 2022 | |
| Alcon Vision LLC | $121.81 | 2025 | Simbrinza, Rocklatan, Rhopressa |
| Coopervision INC. | $111.97 | 2025 | Onefit Contact Lens |
| Oyster Point Pharma, INC. | $97.66 | 2022 | |
| Novartis Pharmaceuticals Corporation | $96.28 | 2019 | |
| Apellis Pharmaceuticals, INC. | $90.38 | 2023 | |
| Dompe US, INC. | $82.23 | 2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $34.48 | 2020 | |
| Visioneering Technologies, INC. | $21.53 | 2019 | |
| Allergan, INC. | $18.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Kwok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.